92 related articles for article (PubMed ID: 3829910)
1. Comparable steady-state bioavailability between two preparations of conventional-release procainamide hydrochloride.
Kasmer RJ; Nara AR; Green JA; Chawla AK; Fleming GM
Drug Intell Clin Pharm; 1987 Feb; 21(2):183-6. PubMed ID: 3829910
[TBL] [Abstract][Full Text] [Related]
2. Comparative bioavailability of two oral sustained-release procainamide products.
Baker BA; Reynolds JR; Gleckel L; A'Zary E; Bodenheimer MM
Clin Pharm; 1988 Feb; 7(2):135-8. PubMed ID: 3349748
[TBL] [Abstract][Full Text] [Related]
3. Predicting plasma procainamide concentrations resulting from a sustained-release preparation.
DiPersio DM; Chow MS
Clin Pharm; 1985; 4(2):186-91. PubMed ID: 3987218
[TBL] [Abstract][Full Text] [Related]
4. Sustained-release procainamide: use of serum concentrations to determine dosage.
Reed WE; Cooper MW
South Med J; 1985 Oct; 78(10):1190-3. PubMed ID: 4049036
[TBL] [Abstract][Full Text] [Related]
5. Conversion from intravenous procainamide to oral sustained release tablets in cardiac patients.
Kalin ML; Babich MF; Klinke WP; Hui WK
Can J Cardiol; 1990; 6(1):15-8. PubMed ID: 2310989
[TBL] [Abstract][Full Text] [Related]
6. Serum concentration fluctuation and bioavailability comparison between indomethacin sustained-release and conventional capsules during steady state.
Wang JP; Liu L; Liu X; Yang XY; Li D; Ge GQ; Huang QW
Zhongguo Yao Li Xue Bao; 1992 Jul; 13(4):298-301. PubMed ID: 1456047
[TBL] [Abstract][Full Text] [Related]
7. Steady-state bioavailability of two sustained-release quinidine preparations: quinidine gluconate versus quinidine sulfate.
Taggart WV; Holyoak W
Clin Ther; 1983; 5(4):357-64. PubMed ID: 6871920
[TBL] [Abstract][Full Text] [Related]
8. Conventional and sustained-release procainamide: update on pharmacology and clinical use.
Anderson JL
Clin Ther; 1985; 7(5):618-40. PubMed ID: 3902240
[TBL] [Abstract][Full Text] [Related]
9. [Steady-state plasma and saliva concentrations of procainamide and N-acetyl-procainamide after a sustained release preparation].
Pirovino M; Karlaganis G; Galeazzi RL
Schweiz Med Wochenschr; 1980 Sep; 110(39):1415-9. PubMed ID: 6169144
[TBL] [Abstract][Full Text] [Related]
10. Steady-state pharmacokinetic properties of a 24-hour prolonged-release formulation of ropinirole: results of two randomized studies in patients with Parkinson's disease.
Tompson DJ; Vearer D
Clin Ther; 2007 Dec; 29(12):2654-66. PubMed ID: 18201581
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of extended-release and immediate-release formulations of galantamine at steady state in healthy volunteers.
Zhao Q; Janssens L; Verhaeghe T; Brashear HR; Truyen L
Curr Med Res Opin; 2005 Oct; 21(10):1547-54. PubMed ID: 16238894
[TBL] [Abstract][Full Text] [Related]
12. [Bioavailability of 3 theophylline delayed-release preparations. Comparison of theophylline concentrations in the serum and saliva in the steady state].
Bochsler HP; Meyer UA
Schweiz Med Wochenschr; 1982 Nov; 112(47):1702-10. PubMed ID: 7178872
[TBL] [Abstract][Full Text] [Related]
13. Bioavailability of a slow-release preparation of valproic acid under steady-state conditions.
Klotz U
Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):24-6. PubMed ID: 6799412
[TBL] [Abstract][Full Text] [Related]
14. Comparison of aminophylline and theophylline sustained-release formulations by their bioavailability and steady-state serum levels.
Steinijans VW; Zech K; Fischer R
Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):624-30. PubMed ID: 6668100
[TBL] [Abstract][Full Text] [Related]
15. Absorption kinetics of procainamide in humans.
Manion CV; Lalka D; Baer DT; Meyer MB
J Pharm Sci; 1977 Jul; 66(7):981-4. PubMed ID: 886461
[TBL] [Abstract][Full Text] [Related]
16. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.
González MA; Kisicki J; Straughn AB
Clin Ther; 1994; 16(4):686-92. PubMed ID: 7982257
[TBL] [Abstract][Full Text] [Related]
18. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
Schuppan D; Molz KH; Staib AH; Rietbrock N
Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of oral morphine sulfate in dogs: a comparison of sustained release and conventional formulations.
Dohoo SE; Tasker RA
Can J Vet Res; 1997 Oct; 61(4):251-5. PubMed ID: 9342447
[TBL] [Abstract][Full Text] [Related]
20. Comparative bioavailability study of a conventional and two controlled release oral formulations of Tegretol (carbamazepine)--200 mg.
Revankar SN; Bhatt AD; Desai ND; Bolar HV; Sane SP; Tipnis HP
J Assoc Physicians India; 1999 Sep; 47(9):886-9. PubMed ID: 10778658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
